The expression of the Wilms tumor suppressor gene WT1 is largely restricted to elements of the developing urogenital system. In the fetal kidney, WT1 transcripts are present at low levels in the condensing mesenchyme and at much higher levels in differentiating glomerular epithelium and are not dete
Analysis of the wilms tumor suppressor gene WT1 in endometrial carcinoma
β Scribed by Raymond Rackley; Graham Casey; Xiao-Ian Zhao; David W. Miller; Bryan R. G. Williams; Dr. Max J. Coppes
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 243 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This study reports on the evaluation of the Wilms tumor suppressor gene WT1 in 14 endometrial carcinomas. Despite the fact that several endometrial carcinomas were shown to express WT1, we were unable to demonstrate mutations in the MT1 zinc finger region, suggesting that WT1 does not play a prominent role in the etiology of this malignancy.
π SIMILAR VOLUMES
## Abstract Desmoid tumors (aggressive fibromatosis) are locally invasive soft tissue tumors in which Ξ²βcatenin/TCF3 mediated Wnt signaling is activated. More than 80% of desmoid tumors contain activating mutations in Ξ²βcatenin. It has been shown that the Wnt signaling pathway interacts with Wilms'
## Abstract Expression of the Wilms' tumor gene __WT1__ in __de novo__ lung cancer was examined using quantitative realβtime RTβPCR and immunohistochemistry. Overexpression of the __WT1__ gene was detected by RTβPCR in 54/56 (96%) __de novo__ nonβsmall cell lung cancers examined and confirmed by de